Nutritional supplement drink reduces inflammation and postoperative depression in patients after off-pump coronary artery bypass surgery.
Cardiac rehabilitation
Herbal medicine
Inflammation
Moderate-to-vigorous intensity physical activity
Off-pump coronary artery bypass
Journal
World journal of cardiology
ISSN: 1949-8462
Titre abrégé: World J Cardiol
Pays: United States
ID NLM: 101537090
Informations de publication
Date de publication:
26 Aug 2021
26 Aug 2021
Historique:
received:
28
01
2021
revised:
13
05
2021
accepted:
20
07
2021
entrez:
30
9
2021
pubmed:
1
10
2021
medline:
1
10
2021
Statut:
ppublish
Résumé
Coronary artery bypass grafting is a surgical treatment for ischemic heart disease. Although development in surgical technique and improvement of perioperative management reduced the postoperative complications, some patients still delayed in progress of postoperative rehabilitation. In this study, we aimed to investigate the effect of daily intake of an herbal medicine-containing drink for rehabilitation after surgery in patients with ischemic heart disease. To investigate the effect of taking an herbal medicine-containing, commercially available drink for postoperative rehabilitation in those patients. Patients who underwent isolated off-pump coronary artery bypass (OPCAB) surgery were divided into two groups depend on the timing of the admission to the hospital: the Yunker (YKR) group, that consumed one bottle of a caffeine-free nutritional supplement drink on a daily basis and the control group (CTL) that underwent regular rehabilitation. A total of 229 patients (CTL = 130, YKR = 99) were enrolled. No significant differences were observed in the baseline characteristics between the two groups. The YKR group had a significantly increased number of daily steps postoperatively ( Our results demonstrated that the daily intake of an herbal medicine-containing drink after OPCAB surgery may have beneficial effects on cardiac rehabilitation by reducing inflammation markers and depression.
Sections du résumé
BACKGROUND
BACKGROUND
Coronary artery bypass grafting is a surgical treatment for ischemic heart disease. Although development in surgical technique and improvement of perioperative management reduced the postoperative complications, some patients still delayed in progress of postoperative rehabilitation. In this study, we aimed to investigate the effect of daily intake of an herbal medicine-containing drink for rehabilitation after surgery in patients with ischemic heart disease.
AIM
OBJECTIVE
To investigate the effect of taking an herbal medicine-containing, commercially available drink for postoperative rehabilitation in those patients.
METHODS
METHODS
Patients who underwent isolated off-pump coronary artery bypass (OPCAB) surgery were divided into two groups depend on the timing of the admission to the hospital: the Yunker (YKR) group, that consumed one bottle of a caffeine-free nutritional supplement drink on a daily basis and the control group (CTL) that underwent regular rehabilitation.
RESULTS
RESULTS
A total of 229 patients (CTL = 130, YKR = 99) were enrolled. No significant differences were observed in the baseline characteristics between the two groups. The YKR group had a significantly increased number of daily steps postoperatively (
CONCLUSION
CONCLUSIONS
Our results demonstrated that the daily intake of an herbal medicine-containing drink after OPCAB surgery may have beneficial effects on cardiac rehabilitation by reducing inflammation markers and depression.
Identifiants
pubmed: 34589170
doi: 10.4330/wjc.v13.i8.348
pmc: PMC8436681
doi:
Types de publication
Clinical Trial
Langues
eng
Pagination
348-360Informations de copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: Sato Pharmaceutical Co., Ltd supported this study by providing the nutritional supplement drink (Yunker DCF®) and by defraying the fee for cytokine level measurement.
Références
Ann Card Anaesth. 2015 Jul-Sep;18(3):385-91
pubmed: 26139745
Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):500-5
pubmed: 22075247
Med Sci Sports Exerc. 2019 Jun;51(6):1270-1281
pubmed: 31095084
J Thorac Cardiovasc Surg. 1987 Jan;93(1):65-72
pubmed: 3491934
Physiol Behav. 2015 Nov 1;151:360-8
pubmed: 26255123
Arch Intern Med. 1985 Apr;145(4):689-92
pubmed: 3885891
Bosn J Basic Med Sci. 2017 May 20;17(2):85-94
pubmed: 28284177
MedGenMed. 2004 Dec 16;6(4):46
pubmed: 15775873
Ann Thorac Surg. 2002 Jan;73(1):123-9; discussion 129-30
pubmed: 11833998
Biosci Biotechnol Biochem. 2004 Jan;68(1):138-45
pubmed: 14745176
Heart Lung Circ. 2010 Aug;19(8):445-52
pubmed: 20418159
Heart Lung Circ. 2014 Feb;23(2):144-51
pubmed: 23981523
Gen Thorac Cardiovasc Surg. 2007 Nov;55(11):445-9
pubmed: 18049851
J Ginseng Res. 2017 Oct;41(4):589-594
pubmed: 29021708
Eur J Cardiothorac Surg. 2017 Oct 1;52(4):665-672
pubmed: 28369234
Circulation. 1982 Nov;66(5 Pt 2):III24-8
pubmed: 6982120
Eur J Cardiothorac Surg. 2003 Nov;24(5):757-61
pubmed: 14583309
Int J Cardiol. 1996 Apr 26;53 Suppl:S1-10
pubmed: 8793590
J Psychosom Res. 1995 Apr;39(3):295-304
pubmed: 7636773
Nephrol Dial Transplant. 2008 Sep;23(9):2853-60
pubmed: 18388121
J Cardiopulm Rehabil. 1999 May-Jun;19(3):144-50
pubmed: 10361645
J Card Surg. 2007 Sep-Oct;22(5):445-55
pubmed: 17803591
Top Stroke Rehabil. 2018 Dec;25(8):591-598
pubmed: 30207894
Integr Physiol Behav Sci. 2002 Jul-Sep;37(3):178-87
pubmed: 12435210
Jpn Circ J. 2001 May;65(5):419-23
pubmed: 11348046
Biol Pharm Bull. 2008 Nov;31(11):2108-13
pubmed: 18981582
Am J Cardiol. 1991 Jul 1;68(1):31-4
pubmed: 2058556
J Thorac Cardiovasc Surg. 2016 Jan;151(1):60-77.e1-58
pubmed: 26433633
Complement Ther Med. 2019 Aug;45:98-103
pubmed: 31331589
Ann Thorac Surg. 2000 Mar;69(3):785-91
pubmed: 10750762